Literature DB >> 28004292

CORR Insights®: Periprosthetic Occult Fractures of the Acetabulum Occur Frequently During Primary THA.

Enrique Gomez-Barrena1.   

Abstract

Mesh:

Year:  2016        PMID: 28004292      PMCID: PMC5213967          DOI: 10.1007/s11999-016-5208-2

Source DB:  PubMed          Journal:  Clin Orthop Relat Res        ISSN: 0009-921X            Impact factor:   4.176


× No keyword cloud information.
  5 in total

1.  Intraoperative fractures of the acetabulum during primary total hip arthroplasty.

Authors:  George J Haidukewych; David J Jacofsky; Arlen D Hanssen; David G Lewallen
Journal:  J Bone Joint Surg Am       Date:  2006-09       Impact factor: 5.284

2.  Congenital hip disease in adults. Classification of acetabular deficiencies and operative treatment with acetabuloplasty combined with total hip arthroplasty.

Authors:  G Hartofilakidis; K Stamos; T Karachalios; T T Ioannidis; N Zacharakis
Journal:  J Bone Joint Surg Am       Date:  1996-05       Impact factor: 5.284

3.  Multislice computed tomography for evaluating acetabular defects in revision THA.

Authors:  Eduardo Garcia-Cimbrelo; Mar Tapia; Carmen Martin-Hervas
Journal:  Clin Orthop Relat Res       Date:  2007-10       Impact factor: 4.176

4.  Periprosthetic fractures of the acetabulum during cup insertion: posterior column stability is crucial.

Authors:  G-Yves Laflamme; Etienne L Belzile; Julio C Fernandes; Pascal A Vendittoli; Jonah Hébert-Davies
Journal:  J Arthroplasty       Date:  2014-09-28       Impact factor: 4.757

5.  Cup press fit in uncemented THA depends on sex, acetabular shape, and surgical technique.

Authors:  Eduardo García-Rey; Eduardo García-Cimbrelo; Ana Cruz-Pardos
Journal:  Clin Orthop Relat Res       Date:  2012-11       Impact factor: 4.176

  5 in total
  1 in total

1.  Occult periprosthetic femoral fractures occur frequently during a long, trapezoidal, double-tapered cementless femoral stem fixation in primary THA.

Authors:  Ho Hyun Yun; Jung Taek Lim; Se-Hyun Yang; Phil Sun Park
Journal:  PLoS One       Date:  2019-09-19       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.